Open Access
Cancer-induced Pain Is Associated With Poor Overall Survival of Urothelial Carcinoma Patients Treated With Enfortumab Vedotin
MAMORU HASHIMOTO, KEN FUKIAGE, KOSEI TANIGUCHI, TAKAFUMI MINAMI, TAKAFUMI YANAGISAWA, WATARU FUKUOKAYA, RYOICHI MAENOSONO, YUKI YOSHIKAWA, TAKUYA TSUJINO, MASANOBU SARUTA, KIYOSHI TAKAHARA, YOSUKE HIRASAWA, TAKESHI HASHIMOTO, YOSHIO OHNO, TAKAHIRO KIMURA, RYOICHI SHIROKI and KAZUTOSHI FUJITA; on behalf of ULTRA-J group
In Vivo May 2025, 39 (3) 1533-1539; DOI: https://doi.org/10.21873/invivo.13953
